ePlex Blood Culture ID

ePlex BCID

 GenMark Dx
ePlex - Transforming Multiplex Molecular Testing

Blood Culture Identification Panels

GenMark’s ePlex blood culture Identification panels (ePlex BCID) provide broad coverage of organisms that cause sepsis, aiding in more timely critical treatment decisions.

ePlex BCID enables physicians to rapidly identify clinically relevant bloodstream infections and their resistance genes while also ruling out blood culture contamination which can then lead to faster treatment decisions.

BCID Panels

Sepsis is a race against time, get a rapid ID from the most comprehensive panel

59 Distinct reportable targets

Rapid time to result includes resistance markers

Includes a control for rare gram stain misses

The Shortest Hands On Time Possible

The early identification of sepsis is critical to ensuring the best possible patient outcome. GenMark have not only developed a rapid system but also one that requires minimal hands on time for the operator. The simple to use system requires minimal training.

1. Load Sample
2. Load Cartridge
3. Report Results

The difference In Speed Is Clear

90 Minutes – sample to result

2 Minute setup


Since traditional diagnostic methods can take days to identify the causative agents of sepsis, 20-30% of patients receive ineffective initial antibiotic therapy[1], and it is estimated that for every hour effective antibiotics are delayed, the mortality rate for sepsis increases up to 7.6%[2]. Therefore early identification of the cause of sepsis is critical to ensuring better patient outcomes.

Bacterial and fungal organisms responsible for greater than 95%[3] of blood stream infections and their associated resistance genes can be identified in about 1.5 hours after initial bottle culture, saving critical time to diagnosis.

ePlex BCID saves days compared to conventional methods and is designed to:

  • Decrease time to appropriate antimicrobial treatment
  • Reduce hospital length of stay and overall costs
  • Improve antibiotic stewardship and infection control
  • Improve patient outcomes

Comprehensive Coverage of Pathogens and Resistance Genes

Gram Positive Targets

  • Bacillus cereus group
  • Bacillus subtilis group
  • Corynebacterium
  • Cutibacterium acnes
  • (Propionibacterium acnes)
  • Enterococcus
  • Enterococcus faecalis
  • Enterococcus faecium
  • Lactobacillus
  • Listeria
  • Listeria monocytogenes
  • Micrococcus
  • Staphylococcus
  • Staphylococcus aureus
  • Staphylococcus epidermidis
  • Staphylococcus lugdunensis
  • Streptococcus
  • Streptococcus agalactiae (GBS)
  • Streptococcus anginosus group
  • Streptococcus pneumoniae
  • Streptococcus pyogenes (GAS)

Gram Negative Targets

  • Acinetobacter baumannii
  • Bacteroides fragilis
  • Citrobacter
  • Cronobacter sakazakii
  • Enterobacter (non-cloacae complex)
  • Enterobacter cloacae complex
  • Escherichia coli
  • Fusobacterium nucleatum
  • Fusobacterium necrophorum
  • Haemophilus influenzae
  • Klebsiella oxytoca
  • Klebsiella pneumoniae
  • Morganella morganii
  • Neisseria meningitidis
  • Proteus
  • Proteus mirabilis
  • Pseudomonas aeruginosa
  • Salmonella
  • Serratia
  • Serratia marcescens
  • Stenotrophomonas maltophilia

Fungal Targets

  • Candida albicans
  • Candida dubliniensis
  • Candida famata
  • Candida glabrata
  • Candida guilliermondii
  • Candida kefyr
  • Candida krusei
  • Candida lusitaniae
  • Candida parapsilosis
  • Candida tropicalis
  • Cryptococcus gattii
  • Cryptococcus neoformans
  • Fusarium
  • Malassezia furfur
  • Rhodotorula
  • Trichosporon

Resistance Genes

  • mecA
  • vanA
  • mecC
  • VanB

Pan Targets

  • Candida
  • Gram Negative

Resistance Genes

  • CTX-M
  • NDM
  • IMP
  • OXA
  • FPC
  • VIM

Pan Targets

  • Candida
  • Gram Positive

GenMark Dx and ePlex are registered trademarks of GenMark Diagnostics Inc.


Contact Us